Paroxetine Tablet, Film Coated
Product Images NDC 16714-182

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 16714-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Impact Of Paroxetine On The Pharmacokinetics Of Co-administered Drugs (log Scale) (Paroxetine Fig1)

A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC relative to reference values when Paroxetine interacts with various drugs: Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Figure 2. Impact Of Co-administered Drugs On The Pharmacokinetics Of Paroxetine (Paroxetine Fig2)

A forest plot chart showing fold changes with 90% confidence intervals in pharmacokinetic parameters Cmax and AUC for Paroxetine when coadministered with interacting drugs: Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. The x-axis represents change relative to reference, ranging from 0 to 2.*

FDA Label Image

Figure 3. Impact Of Specific Population On The Pharmacokinetics Of Paroxetine (log Scale) (Paroxetine Fig3)

A pharmacokinetic chart depicting fold change and 90% confidence intervals for Cmax, AUC, and Cmin in various populations including renal impairment (mild, moderate, severe), hepatic impairment, older adults (>65 years) at different doses, and males. The x-axis shows change relative to reference on a logarithmic scale from 0.5 to 50.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablets Bottle))

Paroxetine Tablets USP 10 mg film-coated oral tablets packaging label by NorthStar Rx LLC. The label indicates 30 tablets per package, with storage instructions and manufacturer details including Aurobindo Pharma Limited, India. It includes instructions for pharmacists to dispense with a medication guide and dosage information guidance.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

Paroxetine Tablets USP 20 mg film-coated tablets label showing NDC 16714-182-01. The label states it contains 30 tablets and includes storage instructions, manufacturer information (NorthStar Rx LLC), and medication guide details. The label also mentions that each tablet contains paroxetine hydrochloride equivalent to 20 mg paroxetine and directs users to dispensing guidelines with safety closures.*

FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablets Bottle))

Label for Paroxetine Tablets, USP 30 mg film-coated tablets in a 30-count package by NorthStar Rx LLC. The label includes NDC 16714-183-01 and storage instructions. Manufactured by Aurobindo Pharma Limited, India, with dispensing and dosage guidance notes, and a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (40 mg (30 Tablets Bottle))

Paroxetine Tablets, USP 40 mg film-coated tablets packaging label from NorthStar Rx LLC. The label indicates a quantity of 30 tablets, specifies storage instructions, manufacturing details by Aurobindo Pharma Limited in India, and includes a barcode. It is marked Rx only and provides pharmacist dispensing instructions and contact information.*

FDA Label Image

Chemical Structure (Paroxetine Str)

Chemical structure of Paroxetine Hydrochloride, displaying its molecular configuration with fluorophenyl and methylenedioxyphenyl groups, and the hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.